Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure

🏆 Top 20📊 OpenAlex

Most Cited Paper

in Heart Failure Treatment and Management

18 Months Post-Publication

Class of 2026

“Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure”

AuthorsZachary L Cox et al.

Zachary L. Cox

JournalJournal of the American College of Cardiology

Lipscomb University

Citations78

DOI10.1016/j.jacc.2024.02.009

A research intelligence initiative by Pepkio

pri.pepkio.com

Topics

dapagliflozin · Acute heart failure · SGLT2 inhibitors · efficacy · safety

Share on X

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-08-20.

Methodology
Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459